We are live on !
Find out more
Bridgefront Capital Portfolio holdings
AUM
$380M
Turnover
75.28%
1-Year Est. Return
23.98%
This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+23.98%
3 Year Est. Return
+52.09%
5 Year Est. Return
+42.08%
10 Year Est. Return
–
AUM
$380M
AUM Growth
-$22.8M
(-5.7%)
Cap. Flow
-$44.4M
Cap. Flow % of AUM
Cap. Flow %
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
793
New
290
Increased
98
Reduced
98
Closed
307
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$5.28M |
| 2 |
Tyson Foods
TSN
|
+$4.4M |
| 3 |
Coca-Cola
KO
|
+$3.81M |
| 4 |
Occidental Petroleum
OXY
|
+$3.32M |
| 5 |
CME Group
CME
|
+$2.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Take-Two Interactive
TTWO
|
+$4.28M |
| 2 |
TPG
TPG
|
+$3.72M |
| 3 |
Broadcom
AVGO
|
+$3.46M |
| 4 |
Ovintiv
OVV
|
+$3.45M |
| 5 |
Keysight
KEYS
|
+$3.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.29% |
| 2 | Consumer Staples | 13.6% |
| 3 | Healthcare | 13.07% |
| 4 | Industrials | 13.01% |
| 5 | Financials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Harmony Gold Mining
HMY
$9.06B
| $326K | 0.09% |
+21,425
| New | +$356K |
2026 Q2
0 quarters
|
|
352
Extra Space Storage
EXR
$31.6B
| $324K | 0.09% |
+2,232
| New | +$319K |
2026 Q2
0 quarters
|
|
353
Airbnb
ABNB
$96.9B
| $324K | 0.09% |
+2,266
| New | +$309K |
2026 Q2
0 quarters
|
|
354
Tenable Holdings
TENB
$5.32B
| $322K | 0.08% |
+8,726
| New | +$205K |
2026 Q2
0 quarters
|
|
355
Permian Resources
PR
$21.8B
| $321K | 0.08% |
17,428
-109,438
| -86% | -$2.2M |
2025 Q4
2 quarters
|
|
356
International Paper
IP
$19.3B
| $320K | 0.08% |
+8,407
| New | +$288K |
2026 Q2
0 quarters
|
|
357
Shake Shack
SHAK
$2.85B
| $320K | 0.08% |
+5,716
| New | +$430K |
2026 Q2
0 quarters
|
|
358
Kinsale Capital Group
KNSL
$8.23B
| $319K | 0.08% |
966
+278
| +40% | +$89.4K |
2026 Q1
1 quarter
|
|
359
Spyre Therapeutics
SYRE
$9.02B
| $318K | 0.08% |
3,577
-5,075
| -59% | -$370K |
2026 Q1
1 quarter
|
|
360
Brighthouse Financial
BHF
$2.53B
| $317K | 0.08% |
+5,012
| New | +$312K |
2026 Q2
0 quarters
|
|
361
Ameren
AEE
$30.6B
| $317K | 0.08% |
+2,804
| New | +$310K |
2026 Q2
0 quarters
|
|
362
CareDx
CDNA
$4.59B
| $317K | 0.08% |
+11,119
| New | +$242K |
2026 Q2
0 quarters
|
|
363
InMode
INMD
$761M
| $317K | 0.08% |
+21,661
| New | +$302K |
2026 Q2
0 quarters
|
|
364
ConocoPhillips
COP
$185B
| $315K | 0.08% |
3,029
-979
| -24% | -$116K |
2026 Q1
1 quarter
|
|
365
AES
AES
$10.6B
| $315K | 0.08% |
21,471
-27,615
| -56% | -$401K |
2025 Q2
4 quarters
|
|
366
AB InBev
BUD
$158B
| $314K | 0.08% |
+3,813
| New | +$300K |
2026 Q2
0 quarters
|
|
367
New Oriental
EDU
$7.55B
| $314K | 0.08% |
+6,833
| New | +$347K |
2026 Q2
0 quarters
|
|
368
Middleby
MIDD
$5.38B
| $313K | 0.08% |
+1,822
| New | +$275K |
2026 Q2
0 quarters
|
|
369
GeneDx Holdings
WGS
$2.06B
| $313K | 0.08% |
4,561
-851
| -16% | -$48.4K |
2026 Q1
1 quarter
|
|
370
Cognizant
CTSH
$29.1B
| $313K | 0.08% |
8,082
-5,539
| -41% | -$292K |
2026 Q1
1 quarter
|
|
371
Bruker
BRKR
$8.7B
| $313K | 0.08% |
5,196
-12,623
| -71% | -$589K |
2026 Q1
1 quarter
|
|
372
Arcutis Biotherapeutics
ARQT
$4.03B
| $310K | 0.08% |
+11,825
| New | +$275K |
2026 Q2
0 quarters
|
|
|
373
Keysight
KEYS
$52.3B
| $309K | 0.08% |
883
-10,028
| -92% | -$3.42M |
2026 Q1
1 quarter
|
|
374
Cogent Biosciences
COGT
$5.38B
| $308K | 0.08% |
+7,957
| New | +$278K |
2026 Q2
0 quarters
|
|
375
Halozyme
HALO
$14.9B
| $307K | 0.08% |
+3,921
| New | +$267K |
2026 Q2
0 quarters
|
|
Similar funds
SC
Bridgefront Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Bridgefront Capital held 793 positions worth $380M, down 5.7% from $402M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bridgefront Capital withdrew a net $44.4M in Q2 2026, closing 307 positions and reducing 98 holdings. Its most notable exit was Take-Two Interactive, an estimated $4.28M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Bridgefront Capital opened a new position in Colgate-Palmolive worth $5.53M.
- Bridgefront Capital's largest Q2 2026 buy was Colgate-Palmolive: 60,327 shares worth $5.53M.
- Bridgefront Capital added most to Tyson Foods in Q2 2026, an estimated $4.4M increase.
- Bridgefront Capital's biggest Q2 2026 reduction was TPG, cutting an estimated $3.72M.
- Bridgefront Capital fully exited Take-Two Interactive in Q2 2026, selling an estimated $4.28M.
- Bridgefront Capital's ten largest holdings make up 11% of its $380M portfolio in Q2 2026.
- Bridgefront Capital opened 290 new positions and closed 307 in Q2 2026.
- Bridgefront Capital's portfolio value fell 5.7% quarter-over-quarter to $380M.
Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.